article thumbnail

Treatment options for Crohn’s disease expand after Rinvoq approval

Pharmaceutical Technology

AbbVie anticipates Rinvoq sales to exceed $7.5bn in 2025 and for the peak revenues from both drugs to exceed Humira’s peak sales by 2027. The FDA has recommended that patients start with 45mg Rinvoq once daily for 12 weeks, with a maintenance dosage of 15mg following the 12-week period.

article thumbnail

HPAPI contract manufacturing to value $14.6 billion by 2030

European Pharmaceutical Review

However, due to the small volumes required for dosage, small-scale providers are also gaining importance, findings from the report show. The oral solid dosage (OSD) form segment is expected to see the biggest rate spike during the forecast period, according to the projections.

Dosage 92
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Personalized Medicine Requires a New Approach to Quality Control

Syner-G

It guarantees delivery of the right drug and the right dosage at precisely the right time , tailored specifically for that person. Cell and gene therapies have been subjects of research for some time, but they have gained traction in real-world medicine and are projected to reach a market value of more than $36 billion by 2027.

article thumbnail

MAPPing a New Route: FDA Updates MAPP on Suitability Petitions

FDA Law Blog: Biosimilars

Taking a step back, a Suitability Petition is used when an ANDA applicant wants to submit an ANDA that differs from its Reference Listed Drug in strength, dosage form, route of administration, or, in the case of a combination drug, active ingredient. Under 21 C.F.R.

Dosage 59
article thumbnail

Key developments in pharmaceutical manufacturing – September 2023

European Pharmaceutical Review

A €25 million drug delivery manufacturing investment To boost capacity in producing user-friendly oral dosage forms, German CDMO HERMES Pharma announced in September it is investing €25 million in its manufacturing capabilities. Subject to planning permission, the site is expected to be opened by 2028.

article thumbnail

Top Performing Drug of 2021 - Trulicity (February Edition)

PharmaShots

Active Ingredient: dulaglutide Dosage Forms & Strengths: Injection: 0.75 In the US, Trulicity is protected by a compound patent (2027) and by biologics data protection (2026). mL, 3 mg/0.5 Hence, it needs to protect its patent as Trulicity patents are very vital to the company’s business as a whole.

article thumbnail

AstraZeneca’s Challenge to Price Negotiation Fails in Federal District Court

FDA Law Blog: Biosimilars

First, AstraZeneca alleged that CMS improperly defined a “qualifying single source drug” to include all dosage forms and strengths of the drug marketed by the manufacturer with the same active moiety or ingredient—even if those different forms and strengths were approved under different NDAs.

Dosage 64